|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 29 of 56 found articles
| Title: |
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial |
| Author: |
Bracarda, Sergio Bamias, Aristotelis Casper, Jochen Negrier, Sylvie Sella, Avishay Staehler, Michael Tarazi, Jamal Felici, Alessandra Rosbrook, Brad Jardinaud-Lopez, Monica Escudier, Bernard |
| Appeared in: |
Clinical genitourinary cancer |
| Paging: | Volume 17 (2019) nr. 3 pages e689-e703 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 29 of 56 found articles
| << previous | next >> |